DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
JNJ-68284528
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-68284528
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FXR-450
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FXR-450
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-05230907
1
Unknown
Investigational
Unknown
Unknown
Cerebral Hemorrhage
Unknown
PF-05230907
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MLN-8054
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Neoplasms; Pancreatic Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
MLN-8054
×
Maximum Phase:
1
First Approval:
None
UNII:
BX854EHD63
Molecule Type:
Small molecule
Molecular Formula:
C25H15ClF2N4O2
Molecular Weight:
476.87
AlogP:
5.87
PSA:
87.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NORCANTHARIDIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NORCANTHARIDIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8452E71EO7
Molecule Type:
Small molecule
Molecular Formula:
C8H8O4
Molecular Weight:
168.15
AlogP:
-0.14
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
DMUC-4064A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DMUC-4064A
×
Maximum Phase:
1
First Approval:
None
UNII:
D5STG0624V
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOBELINE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity
Unknown
LOBELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
D0P25S3P81
Molecule Type:
Small molecule
Molecular Formula:
C22H27NO2
Molecular Weight:
337.46
AlogP:
4.24
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
6.0
Source:
KANAMYCIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KANAMYCIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
EQK9Q303C5
Molecule Type:
Small molecule
Molecular Formula:
C18H36N4O11
Molecular Weight:
484.5
AlogP:
-7.29
PSA:
282.61
HBD:
11.0
HBA:
#RotB:
6.0
Source:
CESIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CESIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
1KSV9V4Y4I
Molecule Type:
Small molecule
Molecular Formula:
Cs
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AG-270
1
Unknown
Investigational
Unknown
Unknown
Lymphoma
Unknown
AG-270
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DHES0815A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DHES0815A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMP-110
1
Unknown
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
AMP-110
×
Maximum Phase:
1
First Approval:
None
UNII:
7J6GS9QIF0
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SU-9516
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cyclin-dependent kinase 2 inhibitor
SU-9516
×
Maximum Phase:
1
First Approval:
None
UNII:
FD2SWT2SDI
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O2
Molecular Weight:
241.25
AlogP:
1.91
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
2.0
Source:
E-7820
1
Small molecule
Investigational
Unknown
Unknown
Colonic Neoplasms; Lymphoma; Neoplasms; Rectal Neoplasms
Unknown
E-7820
×
Maximum Phase:
1
First Approval:
None
UNII:
TVH5K7949N
Molecule Type:
Small molecule
Molecular Formula:
C17H12N4O2S
Molecular Weight:
336.38
AlogP:
3.02
PSA:
109.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIFIRAFENIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
LIFIRAFENIB
×
Maximum Phase:
1
First Approval:
None
UNII:
8762XZS5ZF
Molecule Type:
Small molecule
Molecular Formula:
C25H17F3N4O3
Molecular Weight:
478.43
AlogP:
5.3
PSA:
89.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PF-06815345
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
Unknown
PF-06815345
×
Maximum Phase:
1
First Approval:
None
UNII:
4H9X9HO87K
Molecule Type:
Small molecule
Molecular Formula:
C27H29ClFN9O4
Molecular Weight:
598.04
AlogP:
4.02
PSA:
142.18
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Myositis, Inclusion Body
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REGN-3048
1
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
REGN-3048
×
Maximum Phase:
1
First Approval:
None
UNII:
8HPY7RGH6D
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IGM-2323
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IGM-2323
×
Maximum Phase:
1
First Approval:
None
UNII:
F3HG38I0T1
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-131
1
Unknown
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
MIP-1095 I-131
×
Maximum Phase:
1
First Approval:
None
UNII:
7DM27RQ9V0
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECLISTAMAB
1
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Hematologic Neoplasms
T cell surface glycoprotein CD3 binding agent
TECLISTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
54534MX6Z9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NNZ-2591
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NNZ-2591
×
Maximum Phase:
1
First Approval:
None
UNII:
2T1HU6069S
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O2
Molecular Weight:
194.23
AlogP:
0.05
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MIK-665
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Unknown
MIK-665
×
Maximum Phase:
1
First Approval:
None
UNII:
801XYWHNOS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HU8F4
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HU8F4
×
Maximum Phase:
1
First Approval:
None
UNII:
NL06848HBQ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB-85635
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SB-85635
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISMUTH TRIBROMOPHENATE
1
Unknown
Investigational
Unknown
Unknown
Infections
Unknown
BISMUTH TRIBROMOPHENATE
×
Maximum Phase:
1
First Approval:
None
UNII:
5K96Y7WG8T
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALMANGAFODIPIR
1
Unknown
Investigational
Unknown
Unknown
Peripheral Nervous System Diseases
Unknown
CALMANGAFODIPIR
×
Maximum Phase:
1
First Approval:
None
UNII:
N0JZU0WGU5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELIMUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine-protein kinase ATR inhibitor
ELIMUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H21N7O
Molecular Weight:
375.44
AlogP:
2.65
PSA:
84.75
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AZD-8165
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8165
×
Maximum Phase:
1
First Approval:
None
UNII:
7WO8I5IY24
Molecule Type:
Small molecule
Molecular Formula:
C23H21ClFN7O4
Molecular Weight:
513.92
AlogP:
2.35
PSA:
131.67
HBD:
1.0
HBA:
#RotB:
8.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
1
2
…
102
103
104
105
106
107
108
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA